Loading clinical trials...
Loading clinical trials...
Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Efavirenz Once Daily Over 10 Days Following Drug Intake Cessation in Healthy Volunteers
Conditions
Interventions
Atripla®
Locations
1
United Kingdom
St Stephen's Centre
London, United Kingdom
Start Date
June 1, 2010
Primary Completion Date
October 1, 2010
Completion Date
October 1, 2010
Last Updated
November 1, 2010
NCT04929028
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT05897099
Lead Sponsor
St Stephens Aids Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions